Clinical Trial Update: A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating three dosage strengths of Almotriptan Malate (AXERT) for acute treatment of migraine in adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Axert (Almotriptan)

Snippet

Sponsor: Janssen-Ortho LLC | Conditions: Migraine | Phase 3 | Status: COMPLETED